AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis
- Status
- TERMINATED
- Phase
- PHASE4
A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE2
MARS - Monitored Atherosclerosis Regression Study
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Predicting the Response to Montelukast by Genetic Variation in Asthmatics
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of an Oral Growth Hormone Drug in the Treatment of Fibromyalgia
- Status
- COMPLETED
- Phase
- PHASE2
The Ribavirin Pregnancy Registry
- Status
- TERMINATED
- Phase
- N/A
Study to Treat Uveitis Associated Macular Edema
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Examine the Effects of an Experimental Drug on Postmenopausal Osteoporosis (MK-0822-004)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Oral Ridaforolimus (AP23573, MK-8669) to Treat Patients With Refractory or Advanced Malignancies (MK-8669-016 AM4)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE1
An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia (0524A-032)
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1))
- Status
- COMPLETED
- Phase
- PHASE1
MK0457 in Patients With Leukemia (0457-003)
- Status
- COMPLETED
- Phase
- PHASE1
Ridaforolimus (AP23573/MK-8669) in Participants With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)(MK-8669-017)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978AM3)(TERMINATED)
- Status
- TERMINATED
- Phase
- PHASE3
V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)
- Status
- COMPLETED
- Phase
- PHASE3
A Measles, Mumps, and Rubella Investigational Vaccine Trial (V205C-010)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE2
An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)
- Status
- COMPLETED
- Phase
- PHASE2